A Natural History Study of HIV Acquired in Infancy or Childhood
Background:
Highly active antiretroviral therapy (HAART) has altered the natural history of HIV disease
in children.
The pediatric cohort in this country offers a tremendous opportunity to understand the
effect of HIV and ARTs on key developmental and maturational processes.
A thorough understanding of the impact of HIV and ARTs on these long-term processes is
extremely relevant as ART programs for HIV-infected children are being developed around the
world.
Objective:
To explore the clinical features and impact of HIV infection and antiretroviral therapy in
an HIV-infected pediatric cohort.
Eligibility:
Known HIV disease and followed in the NCI pediatric HIV program as of December 2004, or
HIV-infected sibling of a participant.
Elgibility for the cardiac sub-study is expanded to include any person with HIV acquired in
infancy or young childhood who is older than 7 and meets other inclusion criteria.
Eligibility for cardiac sub-study will also include HIV uninfected subjects (18-30 years of
age) who will server as a control group.
Design:
Serial evaluations of pubertal development, bone mineralization, body composition and fat
distribution, hepatic, renal, and cardiac status, and behavioral, cognitive, and
academic/vocational outcome.
Findings may be shared with the multicenter Pediatric HIV/AIDS Cohort Study and lead to more
intensive, focused substudies.
Observational
N/A
Rohan Hazra, M.D.
Principal Investigator
National Cancer Institute (NCI)
United States: Federal Government
070087
NCT00924365
February 2007
Name | Location |
---|---|
National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda, Maryland 20892 |